Eiko Lifesciences Ltd
Ticker: EIKO
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
50.47
Market Cap
69.25
Debt/Equity
0.0484
ROE %
PB
1.2147
Promoter %
37.168
Pledge %
0.000
1Y Rev Growth %
5Y Rev Growth %
NP Margin %
5.919
NP Margin 5Y Avg %
Trading Reference
1M Return %
-6.447
6M Return %
-4.485
1Y Return %
-25.329
% Away 52W High
48.365
% Away 52W Low
20.167
Daily Volume
8159
Investment Verdict
Buy
Score 82/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 21/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Eiko Lifesciences Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is a potential for significant upside. However, if it falls below the support, downside risk increases.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
K
Kotak Nifty PSU Bank ETF
The Kotak Nifty PSU Bank ETF presents a decent investment opportunity, but investors should be cautious of the inherent risks and sector challenges.
View details
E
Eros International Media Ltd
Eros International Media Ltd presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Raj Oil Mills Ltd
Raj Oil Mills Ltd shows potential but faces significant risks and challenges in growth and market sentiment.
View details
F
Filtra Consultants and Engineers Ltd
Filtra Consultants and Engineers Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
D
Dutron Polymers Ltd
Dutron Polymers Ltd shows potential for growth but faces challenges in valuation and execution risks.
View details
T
Titan Intech Ltd
Titan Intech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
V
Vistar Amar Ltd
Vistar Amar Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
T
Three M Paper Boards Ltd
Three M Paper Boards Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised due to valuation concerns and execution risks.
View details
A
Alliance Integrated Metaliks Ltd
Alliance Integrated Metaliks Ltd shows moderate potential with some growth opportunities, but faces challenges in profitability and market execution.
View details
I
Invesco India Gold Exchange Traded Fund
The fund shows potential but has several risks that could impact performance.
View details
C
Celebrity Fashions Ltd
Celebrity Fashions Ltd is facing multiple challenges in terms of growth, profitability, and market perception, making it a risky investment at this time.
View details
A
Ahlada Engineers Ltd
Ahlada Engineers Ltd shows some potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
W
Wires and Fabriks (SA) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kothari Fermentation and Biochem Ltd
Kothari Fermentation and Biochem Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability metrics. Caution is advised due to valuation concerns and execution risks.
View details
R
Raminfo Ltd
Raminfo Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
A
Astron Paper & Board Mill Ltd
Astron Paper & Board Mill Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
Business Overview
Eiko Lifesciences Ltd is a pioneering biotechnology company focused on developing innovative solutions in the healthcare sector. Catering to hospitals, clinics, and research institutions, Eiko aims to enhance patient care through advanced medical technologies. Their commitment to quality and research-driven approach ensures that they deliver effective and reliable products. As a trusted partner in the healthcare ecosystem, Eiko plays a crucial role in improving health outcomes and supporting medical professionals.
- Pioneering biotechnology innovations
- Focus on enhancing patient care
- Trusted partner for healthcare providers
- Commitment to quality and research
- Supports hospitals and clinics in India
Investment Thesis
Eiko Lifesciences Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth potential in digital services, and attractive valuation compared to peers. This positions the company favorably in the evolving healthcare landscape, making it a worthy addition to any portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth runway in digital services aligns with industry trends.
- Attractive valuation metrics compared to peers indicate potential for upside.
- Focus on innovation and technology positions Eiko for future success.
- Solid fundamentals and market positioning make it a reliable investment choice.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare solutions
- Innovative product pipeline
- Strategic partnerships in biotech
- Expansion into international markets
Risks ⚠️
- Regulatory hurdles in drug approval
- Intense competition in the sector
- Market volatility affecting stock price
- Dependence on key product sales
Peer Perspective
Eiko Lifesciences Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's Laboratories, with rerating potential hinging on sustained margin stability and accelerated revenue growth in emerging markets.
Future Outlook
Eiko Lifesciences Ltd is well-positioned for growth, driven by innovative product developments and expanding market opportunities; however, successful execution and cost control will be crucial to fully realize its potential.
📊 Stock Investment Checklist (100 Points)
Eiko Lifesciences Ltd • Updated: 2025-09-16 20:38:50
-
10BusinessHighThe sector is promising with increasing demand for life sciences.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages, indicating lower efficiency.
-
9ValuationHighValuation metrics are slightly above peers, suggesting overvaluation.
-
7BalanceHighModerate debt levels, but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited growth drivers identified, with execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity observed.
Final Score & Verdict
Score 48 / 100
• Risky
Eiko Lifesciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100